Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Dupuy

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Clinical and Experimental Dermatology|February 2, 2023
Bone involvement in primary cutaneous diffuse large B-cell lymphoma, leg-typeClaire Laurent, Caroline Ram-Wolff, Saskia Ingen-Housz-Oro, et al.
Pediatrics|May 31, 2018
Safety of Oral Propranolol for Infantile HemangiomaCatherine Droitcourt, Sandrine Kerbrat, Caroline Rault, et al.
The Journal of Investigative Dermatology|November 25, 2003
Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C)Laurence Michel, Alain Dupuy, Francette Jean-Louis, et al.
Archives of Dermatology|September 24, 2004
Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomasEmmanuelle Tancrède-Bohin, Marius Anton Ionescu, Pauline de La Salmonière, et al.
The American Journal of Dermatopathology|December 11, 2024
Differential Expression of p53 in Mycosis Fungoides, Sezary Syndromes, and Their Transformed FormsAnna Courtois, Pierre Allaume, Maxime Raby, et al.
Cancer Immunology, Immunotherapy : CII|September 4, 2020
Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodiesAlexandra Frelau, Xavier Palard-Novello, Eva Jali, et al.
Fundamental & Clinical Pharmacology|February 6, 2026
Real-World Use of Dupilumab in Atopic Dermatitis: Observational Study Results Linked to SNDSAlain Dupuy, Anne-Claire Fougerousse, Pierre-André Bécherel, et al.
Clinical and Experimental Dermatology|February 17, 2024
Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndromeHortense Lecoeuvre, François Le Gall, Cécile Le Naoures, et al.
Journal of the National Cancer Institute|March 7, 2022
The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving ImmunotherapyFlorence Poizeau, Sandrine Kerbrat, Frédéric Balusson, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|February 5, 2005
ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patientsAmel Mebazaa, Alain Dupuy, Michel Rybojad, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Clinical and Experimental Dermatology|February 2, 2023
Bone involvement in primary cutaneous diffuse large B-cell lymphoma, leg-typeClaire Laurent, Caroline Ram-Wolff, Saskia Ingen-Housz-Oro, et al.
Pediatrics|May 31, 2018
Safety of Oral Propranolol for Infantile HemangiomaCatherine Droitcourt, Sandrine Kerbrat, Caroline Rault, et al.
The Journal of Investigative Dermatology|November 25, 2003
Arsenic trioxide induces apoptosis of cutaneous T cell lymphoma cells: evidence for a partially caspase-independent pathway and potentiation by ascorbic acid (vitamin C)Laurence Michel, Alain Dupuy, Francette Jean-Louis, et al.
Archives of Dermatology|September 24, 2004
Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomasEmmanuelle Tancrède-Bohin, Marius Anton Ionescu, Pauline de La Salmonière, et al.
The American Journal of Dermatopathology|December 11, 2024
Differential Expression of p53 in Mycosis Fungoides, Sezary Syndromes, and Their Transformed FormsAnna Courtois, Pierre Allaume, Maxime Raby, et al.
Cancer Immunology, Immunotherapy : CII|September 4, 2020
Increased thyroid uptake on 18F-FDG PET/CT is associated with the development of permanent hypothyroidism in stage IV melanoma patients treated with anti-PD-1 antibodiesAlexandra Frelau, Xavier Palard-Novello, Eva Jali, et al.
Fundamental & Clinical Pharmacology|February 6, 2026
Real-World Use of Dupilumab in Atopic Dermatitis: Observational Study Results Linked to SNDSAlain Dupuy, Anne-Claire Fougerousse, Pierre-André Bécherel, et al.
Clinical and Experimental Dermatology|February 17, 2024
Clinical and histological features of histiocytoid Sweet syndrome associated with VEXAS syndromeHortense Lecoeuvre, François Le Gall, Cécile Le Naoures, et al.
Journal of the National Cancer Institute|March 7, 2022
The Association Between Antibiotic Use and Outcome Among Metastatic Melanoma Patients Receiving ImmunotherapyFlorence Poizeau, Sandrine Kerbrat, Frédéric Balusson, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|February 5, 2005
ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patientsAmel Mebazaa, Alain Dupuy, Michel Rybojad, et al.
Pageof 13